New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
10:09 EDTMNKDMannKind rallies after global licensing agreement for Afrezza
The company and Sanofi (SNY) entered into a worldwide exclusive agreement to develop and commercialize Afrezza Inhalation Powder. The stock is up over 15.5% at time of writing to $9.40, off earlier highs. At that price, next resistance is at $9.63. Support is at $9.29.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
05:58 EDTMNKDStocks with implied volatility movement; MNKD SHPG
Subscribe for More Information
October 20, 2014
06:52 EDTMNKDMannKind initiated with a Neutral at Goldman
Target $6.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use